Remedy Plan Remedy Plan Therapeutics is a biotechnology company developing drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis. | ABL Bio ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease. | ![]() Alchemab Therapeutics Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies. | |
Founding Date | Founding Date 2011 | Founding Date 2016 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations HQ | Locations HQ | Locations London, GB HQ Babraham, GB |
Employees | Employees 15 | Employees 615% increase | Employees 512% decrease |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 65m (almost 8 years ago) | Latest funding round $ 71.8m (about 5 years ago) |
Total funding raised | Total funding raised $ 10.1m | Total funding raised $ 90.8m | Total funding raised $ 71.8m |
ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.
View company
Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies.
View company